Globus Medical (GMED) | Stock Overview & Key Data
Globus Medical Performance Comparison
Stock Range
Today's Range
Low: $59.74
High: $60.89
on August 15, 2025
52 Week Range
Low: $51.79
High: $94.93
on August 1, 2025
on January 30, 2025
All-Time High: $94.93 on January 27, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$8.4B
EPS
2.58
P/E Ratio (TTM)
23.98
Forward P/E
18.09
P/B Ratio
1.95
PEG Ratio
18.09
Div. Yield
N/A
ROE
8.62%
Beta
1.204
Debt to Equity
2.83
Financial Highlights
Profitability
Gross Margin
66.62%
Operating Margin
17.33%
Profit Margin
13.58%
Returns and Earnings
Return on Assets (TTM)
5.82%
Return on Equity (TTM)
8.62%
EBITDA
$596.6M
Net Income (TTM)
$356.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$19.11
Quarterly Revenue Growth (YoY)
18.40%
Quarterly Earnings Growth (YoY)
538.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Globus Medical GMED | 8.36B Mid-cap | 3.27% | 8.41% | 4.76% | -28.60% | -25.98% | -13.30% | -6.53% | 13.36% |
| Abbott Laboratories ABT | 228.04B Mega-cap | -1.88% | 0.20% | -1.20% | 1.21% | 16.14% | 18.69% | 19.71% | 28.66% |
| Boston Scientific BSX | 152.25B Large-cap | 0.03% | -0.30% | -1.61% | -2.07% | 15.43% | 31.85% | 145.53% | 168.46% |
| Penumbra PEN | 9.69B Mid-cap | 5.21% | 7.03% | -8.10% | -6.68% | 5.43% | 32.81% | 55.73% | 8.75% |
| Masimo MASI | 8.16B Mid-cap | 6.32% | -3.86% | -0.34% | -14.69% | -8.72% | 24.66% | -1.19% | -29.80% |
| Bio-Rad Laboratories BIO | 7.40B Mid-cap | 8.12% | 15.49% | 17.46% | 0.87% | -12.42% | -12.26% | -44.01% | -44.85% |
Ownership & Short Interest
Insider Ownership
0.69%
Institutional Ownership
100.94%
Shares Short
5M
Short Ratio
2.94
Short % of Shares Outstanding
4.76%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Globus Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Globus Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GMED's 52-week high and low?
- In the last 52 weeks, Globus Medical reached a high of $94.93 (on January 30, 2025) and a low of $51.79 (on August 1, 2025).
- What is the market cap and P/E ratio for GMED?
- Curious about Globus Medical's size and valuation? Its market capitalization stands at 8.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 23.98, and the forward P/E (looking ahead) is 18.09.
- Does GMED pay dividends? If so, what's the yield?
- As for dividends, Globus Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Globus Medical's main competitors or similar companies to consider before investing?
When looking at Globus Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT228.04B Healthcare Medical Devices 18.69% 19.71% Boston Scientific
BSX152.25B Healthcare Medical Devices 31.85% 145.53% Penumbra
PEN9.69B Healthcare Medical Devices 32.81% 55.73% Masimo
MASI8.16B Healthcare Medical Devices 24.66% -1.19% Bio-Rad Laboratories
BIO7.40B Healthcare Medical Devices -12.26% -44.01% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Globus Medical Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Globus Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.62%, the Debt to Equity ratio from the most recent quarter is 2.83, and its Gross Profit Margin stands at 66.62%.
- What is the recent revenue and earnings growth for GMED?
- Looking at Globus Medical's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 18.40%, and quarterly earnings saw a YoY growth of 538.70%.
- How much of GMED stock is held by insiders and institutions?
- Wondering who owns Globus Medical stock? Company insiders (like executives and directors) hold about 0.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 100.94%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.